New report ignores benefits of patent system to innovation and patients

A recentreport from the Initiative for Medicines, Access& Knowledge – known as I-MAK – highlights fundamental misunderstandings about America’s patent system and how it benefits patients and medical innovation. I-MAK accuses biopharmaceutical companies of blocking competition and gaming the system by patenting new innovations, when in reality, new patents do n ot extend old patents, and they do not prevent competitors from launching new products.

Source: The Catalyst - September 30, 2022 Category: Pharmaceuticals Authors: Megan Van Etten Tags: Patents Intellectual Property Source Type: news